OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP) Invention Versus Waitlisted Group in...

Area of Science:

• Cardiovascular Health
• Health Technology
• Health Disparities

Background:

• Hypertension treatment adherence is challenging for minority populations.
• Technology-based interventions (TBI) offer a promising approach for hypertension self-management.
• Effective blood pressure control can lead to improved long-term health outcomes.

Purpose of the Study:

• To evaluate the efficacy of the OPTIMA-BP technology-based intervention.
• To improve blood pressure control, health-related quality of life (HRQOL), and medication adherence in African Americans with hypertension.
• To assess the long-term compliance of hypertension management strategies.

Main Methods:

• A prospective, 2-arm randomized trial involving African American older adults (≥50 years) with hypertension.
• Participants were randomized (1:1) to either the OPTIMA-BP intervention (n=104) or a waitlist control group (n=104) for 12 months.
• The OPTIMA-BP intervention included a web-based education module, mHealth app for medication adherence, home BP monitoring, and nurse counseling.

Main Results:

• Participant recruitment commenced in March 2022 and is ongoing.
• Preliminary findings are expected to be disseminated in Summer 2025.
• The primary endpoints are achieving a blood pressure below 130/80 mmHg and improved HRQOL.

Conclusions:

• Technology-based interventions combined with standard care can improve blood pressure control.
• This approach offers a unique strategy for secondary cardiovascular disease prevention in high-risk populations.
• OPTIMA-BP shows potential for enhancing hypertension self-management and outcomes in African Americans.